Search results

Source:

Medicines Management Collection (Remove filter)

Published by Research In Social & Administrative Pharmacy : Rsap, 12 July 2018

INTRODUCTION: While many attempts have been made to reduce prescribing errors (PEs), they persist. PE is not in itself a behaviour, but a consequence...

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

British Association of Dermatologists - BAD (Remove filter)

Published by British Association of Dermatologists (BAD), 01 June 2014

Most prescribing uses licensed medicines whose safety and efficacy are assured. For many common dermatological diseases including psoriasis and eczema, the range of licensed medicines is limited.

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

All Wales Medicines Strategy Group - AWMSG (Remove filter)

Published by All Wales Medicines Strategy Group (AWMSG), 01 December 2018

Four medicines/medicine groups have been identified for the purposes of this document: omega-3 fatty acid compounds, oxycodone and naloxone combination product, paracetamol and tramadol combination...

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

All Wales Medicines Strategy Group - AWMSG (Remove filter)

Published by All Wales Medicines Strategy Group (AWMSG), 13 November 2019

This document is intended for non-specialist practitioners engaged in the prescribing and monitoring of medical therapies used in the management of gender dysphoria.*

Read Summary

Type:

Prescribing and Technical Information (Remove filter)